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Abstract: 
Two accurate, simple and sensitive spectrophotometric methods were developed for determination of omeprazole sodium and ranitidine 
hydrochloride in bulk and pharmaceutical dosage forms. The first method was based on the reaction of these drugs with 2, 4- 
dinitrofluorobenzene producing yellow colored products measured at λmax 470 nm and 420 nm for omeprazole sodium and ranitidine HCl, 
respectively. Beer’s law was obeyed in the concentration range from (5-40 µg.ml-1) for omeprazole sodium and (30-180 µg.ml-1) for 
ranitidine HCl with molar absorpitivity 9.202 x 103 Lmol-1cm-1 and 1.778 x 103 Lmol-1cm-1, respectively. The second method was based 
on the reaction of omeprazole sodium and ranitidine HCl with 4- Chloro-7-nitrobenzen-2-oxa-1, 3-diazole producing yellow colored adducts 
measured at λmax 481 nm and 468 nm for omeprazole sodium and ranitidine HCl, respectively. This method was accompanied with a 
kinetic study for ranitidine HCl. The absorbance-concentration plots were rectilinear over concentration range (2-12 µg.ml-1) and (0.025-0.15 
µg.ml-1) for omeprazole sodium and ranitidine HCl with molar absorpitivity 4.062 x 104 Lmol-1cm-1 and 2.802 x 106 Lmol-1cm-1, 
respectively. These methods hold their accuracy and precision well when applied to the determination of omeprazole sodium and ranitidine 
HCl in their dosage forms.  
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Introduction  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Omeprazole sodium is chemically known as sodium salt of 5-methoxy-2-[[(4-methoxy-3, 
5-dimethyl-2-pyridinyl) methyl] sulfinyl] benzimidazole. 
Omeprazole is officially listed in B.P.2011 [1] and U.S.P.XXXII [2]. It is a proton pump inhibitor, used in 
treatment of peptic ulcer disease and NSAID-associated ulceration, in gastro-esophageal reflux disease and 
the Zollinger-Ellison syndrome [3]. 
A survey of the literature revealed that omeprazole has been estimated in pharmaceuticals by 
UV-spectrophotometry [4-6], spectrofluorimetry [7], flow injection method [8], HPLC [9-11], HPTLC [12, 
13], capillary electrophoresis [14] and electrochemical methods [15, 16]. 
Ranitidine hydrochloride is officially listed in B.P.2011[1] and U.S.P.XXXII[2] and chemically known as 
N-[2-[[[5-[(Dimethylamino) methyl]-2-furanyl] methyl] thio] ethyl]-N`-methyl-2-nitro-1, 1-ethenediamine, 
hydrochloride. 
Ranitidine HCl is a histamine H2-receptor antagonist and inhibits the actions of histamine mediated by 
H2-receptors such as gastric acid secretion and pepsin output. It is used where inhibition of gastric acid 
secretion may be beneficial as in peptic ulcer disease including stress ulceration, gastroesophageal reflux 
disease and selected cases of persistent dyspepsia [3]. 
Various analytical methods have been reported for the assay of ranitidine HCl in its pure form as well as in 
pharmaceutical formulations. These methods include spectrophotometric, [17-19] potentiometric methods [20, 
21], and HPLC methods [22-24]. 
This paper reports simple, sensitive, economical and accurate spectrophotometric methods for the analysis 
of omeprazole sodium and ranitidine hydrochloride in their pure and dosage forms. The results of the analysis 
were validated by statistical analysis and recovery studies. Common additives used as excipients in 
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pharmaceutical dosage forms do not interfere in the determination of the studied drugs.  
Material and methods 
Apparatus: 
Labomed® Spectro UV-VIS Double Beam (UVD-2950) Spectrophotometer with matched 1 cm quartz 
cells connected to windows compatible computer using UV Win 5 Software v5.0.5.  
Digital pH-meter (Cosort P400) ® for pH adjustment. 
Thermostatically controlled (Wisebath) ® water bath. 
Materials and reagents:  
All solvents and reagents were of analytical grade and distilled water was used throughout the work. 
Materials: 
Omeprazole sodium (Hikma Pharmaceutical Co., 6th of October City, Egypt) . 
Ranitidine hydrochloride (Sigma Pharmaceutical Industries, Quesna City, Egypt).  
Pharmaceutical preparations: 
The following pharmaceutical preparations were analyzed: 
Pepzol® capsules (Hikma Pharmaceutical Co., 6th of October City, Egypt) labeled to contain 20 mg 
omeprzole per capsule. 
Aciloc® tablets (Sigma Pharmaceutical Industries, Quesna City, Egypt) labeled to contain 300 mg 
ranitidine HCl per tablet. 
Zantac® ampoules (Glaxo Smithkline, Egypt) labeled to contain 50 mg ranitidine HCl per ampoule. 
Reagents: 
2, 4- Dinitrofluorobenzene (DNFB; Sanger’s reagent) (Acros, Newjersey, USA). 
4- Chloro-7-nitrobenzen-2-oxa-1, 3-diazole (NBD-Cl) (Acros, Newjersey, USA). 
Sodium hydroxide (Sd fine-chem limited, industrial estate, Mumbai, India). 
Boric acid, hydrochloric acid and methanol (EL-Nasr Pharm.Chem.Co., Egypt). 
Preparation of materials and reagents: 
Working solutions: 
 Pure drugs: 
Method I: standard solutions of omeprazole sodium and ranitidine hydrochloride (100 µg/ml and 600 
µg/ml) were prepared by dissolving 10 mg and 60 mg of the pure drug respectively in 100ml distilled water in 
a volumetric flask. 
Method II: standard solutions of omeprazole sodium and ranitidine hydrochloride (40 µg/ml and 1µg/ml) 
were prepared by dissolving 4 mg and 0.1 mg of the pure drug, respectively in 100 ml distilled water in a 
volumetric flask. 
2, 4-Dinitrofluorobenzene (DNFB; Sanger’s reagent): 
Fresh solution of 0.3%v/v DNFB in methanol was prepared daily. 
4-Chloro-7-nitrobenzen-2-oxa-1, 3-diazole (NBD-Cl): 
Fresh solution of 0.4%w/v NBD-Cl in methanol was prepared daily.  
Borate buffer solutions: 
Borate buffer solutions (0.2 M) were prepared by mixing appropriate volumes of 0.2 M boric acid and 0.2 
M NaOH (2) and adjusting the pH to 9.8 and 10.8 using the pH-meter. 
General Procedures: 
Authentic drugs: 
Method I 
Accurately measured aliquots of standard solutions containing (50-400 µg/ml) and (300-1800 µg/ml) of 
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omeprazole sodium and ranitidine hydrochloride respectively were transferred into a series of 10-ml 
volumetric flasks, to each flask, 1.5 ml of borate buffer (pH = 10.5) and 0.4 ml and 1.5 ml of 0.3%v/v DNFB 
were added for omeprazole sodium and ranitidine HCl respectively and mixed well. The solutions were 
heated at 70oC and 80oC for 15 and 20 minutes in thermostatically controlled water bath for omeprazole 
sodium and ranitidine HCl respectively. The solutions were cooled and acidified with 1ml of 0.1M HCl. The 
reaction products were diluted to 10 ml with methanol. The absorbances were measured atλmax 470 nm and 
420 nm for omeprazole sodium and ranitidine HCl against the blank.  
Method II 
Accurately measured aliquots of standard solutions containing (20-120 µg/ml),  
(0.25-1.5 µg/ml) of omeprazole sodium and ranitidine hydrochloride, respectively were transferred into a 
series of 10-ml volumetric flasks. 
To each flask, 1ml of borate buffer (pH=10.8) and 1ml of NBD-Cl solution were added in case of 
omeprazole sodium and 0.8 ml of borate buffer (pH=9.8) and 1 ml of NBD-Cl solution were added in case of 
ranitidine HCl and mixed well. 
The solutions were heated for 15, 25 minutes in thermostatically controlled water bath (80, 60oC) for 
omeprazole sodium and ranitidine HCl respectively. 
The solutions were cooled and acidified with 1 ml of 0.1M HCl. The reaction products were diluted to 10 
ml with methanol. 
The absorbances were measured atλmax 481 nm and 468 nm for omeprazole sodium and ranitidine HCl 
against the blank.  
Pharmaceutical preparations: 
Capsules: 
The contents of twenty capsules of Pepzol were emptied and pulverized.  
An accurately weighed amount equivalent to concentration of omeprazole taken in method I and II were 
extracted by shaking with 5 ml 0.01N NaOH three times, the filtrates were collected and transferred to 100 ml 
volumetric flask, completed to the mark with distilled water. Aliquots from these solutions equivalent to those 
in authentic samples were used for the application of the proposed methods applying standard addition 
techniques. 
Tablets 
Twenty tablets of Aciloc were weighed and ground into a fine powder. 
An accurately weighed amount of the powder equivalent to the concentration of ranitidine HCl in method I 
and II were extracted with distilled water three times, the filtrates were collected and transferred to 100 ml 
volumetric flask and completed to the mark with distilled water. Aliquots from these solutions equivalent to 
those in authentic samples were used for the application of the proposed method applying standard addition 
techniques. 
Ampoules: 
Ten ampoules of Zantac were evacuated in 250 ml volumetric flask; the volume was adjusted to 250 ml 
using distilled water. Aliquots from this solution equivalent to those in authentic samples were used for the 
application of the proposed method applying standard addition techniques for both methods. 
Results and Discussion 
2, 4-Dinitrofluorobenzene (DNFB; Sanger’s reagent) is an active aryl halide reacts with primary and 
secondary amines, phenols, thiols and imidazoles forming stable condensation coloured products [25].  
DNFB has been utilized as a chromogen and a fluorogen for the spectrophotometric [26-29] and 
spectrofluorometric [30, 31] determination of many compounds of pharmaceutical interest. 
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Also some drugs have been derivatized with DNFB before estimation with  
HPLC [30, 32].  
4-chloro-7-nitrobenzo-1, 3-diazole (NBD-Cl), is an electroactive halide reagent. It is well known to react 
with primary, secondary amines and thiol groups forming stable condensation coloured products, so it has 
been used as chromogenic [33-36] or fluorogenic [37, 38] reagent in pharmaceutical analysis. It has also been 
used in charge transfere reactions due to its electrophilic properties, where it acts as π-acceptor as in 
determination of some β-blockers [39], skeletal muscle relaxants and antihistaminic drugs [40]. 
This paper shows the possibility of the reaction of DNFB and NBD-Cl with omeprazole sodium and 
ranitidine HCl in alkaline media through nucleophilic substitution reactions. These drugs contain secondary 
amino group which can react with DNFB and NBD-Cl, producing yellow coloured products, shown in 
reaction schemes. This study is accompanied with a kinetic study for the reaction of ranitidine HCl with 
NBD-Cl. The suggested mechanism is explained below.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
       
                                             
    
 
  
 
                                                                         
 
 
 
Scheme (1) Reaction scheme between omeprazole sodium and DNFB 
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Scheme (2) Reaction scheme between ranitidine HCl and DNFB 
 
 
 
 
 
 
 
 
                   
  
 
 
 
  
  
 
 
                        
 
 
 
Scheme (3) Reaction scheme between omeprazole sodium and NBD-Cl 
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Scheme (4) Reaction scheme between ranitidine HCl and NBD-Cl 
Study of the experimental parameters: 
The different experimental parameters affecting the development of the reaction products were 
carefully studied and optimized. Such factors were changed individually while others were kept constant. 
These factors include pH, type of buffer, reagent concentration, temperature, heating time and effect of 
diluting solvent. 
i- Effect of pH and volume of buffer 
Different buffers (borate, phosphate, hexamine) were studied. Borate buffer was found to be the most 
suitable buffer for both methods, Fig. (3 and 4). For method I; 1.5 ml of borate buffer (pH=10.5) for 
omeprazole sodium and ranitidine HCl gave best results. While for method II; the best results were 
obtained on using 1 ml of borate buffer (pH=10.8) in case of omeprazole sodium and 0.8 ml of borate 
buffer (pH= 9.8) in case of ranitidine HCl. Fig. (5 and 6). 
ii- Effect of the reagent concentration. 
The concentrations of the reagents were investigated. For method I; 0.4 ml and 1.5ml of 0.3%v/v 
DNFB solution for omeprazole sodium and ranitidine HCl were optimum reagent concentrations. While 
for method II; 1ml of 0.4%w/v NBD-Cl solution for omeprazole sodium and ranitidine HCl were 
sufficient for production of maximum and reproducible color intensity. Fig. (7 and 8). 
iii- Effects of temperature and heating time 
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It was found that the reaction proceeds very slowly at room temperature. A gradual increase in the 
temperature produced a significant increase in the absorbance. For method I; the reaction proceeded at 
70oC and 80oC for 15 and 20 minutes for omeprazole sodium and ranitidine HCl, respectively. For 
method II; the reaction was carried out at 80oC and 60oC for 15 and 25 minutes for omeprazole sodium 
and ranitidine HCl respectively. Fig. (9, 10, 11 and 12). 
iv- Effect of HCl addition  
Acidification of the reaction mixture prior to measurement of the absorbance value remarkably 
decreased the background absorbance. In method I; acidification of the medium with 1 ml of 0.1M HCl 
transfers yellow 2, 4-dinitrophenolate into colorless 2, 4-dinitrophenol[41]. While in method II; the 
absorbance of the hydrolysis product of NBD-Cl, namely, 4-hydroxy-7-nitrobenzo-2-oxa-1, 3-diazole 
(NBD-OH) is quenched by decreasing the pH of the reaction medium using 1 ml of 0.1M HCl [42]. Fig 
(13 and 14). 
v- Effect of diluting solvent 
Different organic solvents were tested as methanol, acetone, acetonitrile, dimethylformamide and 
isopropanol, methanol gives reasonable absorption intensity with maximum product stability for method 
I and II. 
Stoichiometry of the reaction: 
The molar ratio of the reagent and both drugs in the reaction mixture was studied according to Job’s 
method of continuous variation [43]. The molar ratio was found to be 1:1 (drug: reagent) in both 
methods. 
Validation of the proposed method 
The validity of the proposed methods was tested according to ICH recommendations [44]. 
Linearity and Quantification 
Method I 
A linear relationship was obtained for the absorbance of DNFB with the two cited drugs in the 
concentration ranges of (5-40 µg.ml-1) and (30-180 µg.ml-1) for omeprazole sodium and ranitidine HCl 
respectively. 
Method II 
A linear relationship was obtained for the absorbance of NBD-Cl with the two cited drugs in the 
concentration ranges of (2-12 µg.ml-1) and (0.025-0.15 µg.ml-1) for omeprazole sodium and ranitidine 
HCl respectively. 
Under the optimized conditions, the optical and statistical parameters for the proposed methods are 
summarized in table (1). The molar absorpitivity, Sandell’s sensitivity, correlation coefficients, slopes and 
intercepts were listed. 
The good linearity of the calibration graph and the negligible scatter of the experimental points were 
clearly evident from the value of the correlation coefficient and variance. 
The proposed methods were successfully applied for the determination of pure drugs. Performance of 
the proposed methods was assessed by comparing the calculated t and F values with the reference 
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methods [45, 46]. The results showed that the t and F values were less than the tabulated ones indicating 
that there was no significant difference between the proposed and reference methods. Table (2) 
Dosage forms containing omeprazole and ranitidine HCl were analyzed by the proposed methods 
applying the standard addition technique. The obtained results compared with the reference method and 
statistical analysis of the results showed that there is no interference from the common additive and 
excipients, indicating a high selectivity for determining the studied drugs in their dosage forms. Table (3) 
Sensitivity 
The limit of detection (LOD) for the two spectrophotometric methods was calculating using the 
following equation: 
LOD = 3.3S/K 
The limit of quantification, LOQ is defined as; 
LOQ = 10S/K 
Where S is the standard deviation of the three replicate determination values under the same conditions 
as for the sample analysis in the absence of analyte and K is the sensitivity, namely, the slope of 
calibration graph. 
According to these equations, the limits of detection and the limits of quantification were calculated 
and are listed in Table (1). 
Accuracy 
The accuracy of the proposed methods was checked by performing recovery experiments through 
standard addition technique. The results are shown in table (3). No interference from the excipients was 
observed. 
Intraday precision was evaluated by calculating standard deviation (SD) of five replicate 
determinations using the same solution containing pure drug. In the method I; the SD values were 0.109 
and 0.118 for omeprazole sodium and rantidine HCl, respectively. For method II; the SD values were 
0.099 and 0. 115 for omeprazole sodium and rantidine HCl, respectively. The small values of SD 
revealed the precision of the method. 
For interday reproducibility on a day-to-day basis, a series was run, in which the standard drug 
solutions were analyzed each for five days. For method I; the interday SD values were 0.174 and 0.221 
for omeprazole sodium and ranitidine HCl respectively.For method II; the interday SD values were 0.193 
and 0.188 for omeprazole sodium and ranitidine HCl respectively. 
The standard analytical errors, relative standard deviations (RSD) and recoveries obtained by the 
proposed method were found to be acceptable. 
Robustness  
Robustness of the methods was examined by small changes in the method variables such as change in 
pH (± 0.2), change in the volume of the reagent (± 0.1 ml) and change in temperature (± 5oC). 
The minor changes that may take place during the experiment didn’t affect the absorbance of the 
reaction products. 
Kinetic study of the reaction between ranitidine HCl and NBD-Cl: 
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The rate of the reaction was found to be concentration dependent. The rate of the reaction was 
followed with various concentrations of ranitidine HCl in the range of 0.025-0.15 µg/ml. The graph 
shown in (fig.15) indicates that the reaction rate of ranitidine HCl obeys the following equation: 
Rate = k` [drug] n   (1) 
Where k` is the pseudo-order rate constant and n is the order of the reaction. 
The rate of the reaction may be estimated by the variable-time method (47). 
In this method the reaction rate was followed by measuring the change of absorbance at different time 
intervals. Taking logarithms of rates and concentration (Table 4) equation (1) is transformed into: 
Log (rate) =log ΔA/Δt = log k` + n log [drug]              (2) 
Where A is the absorbance and t is the time in seconds. 
Regression of log (rate) versus log (drug) gave the following regression equations: 
Log (rate) = 3.159 + 0.986 log [drug] 
Where r=0.986 and k`= 1.442x103s-1 
Hence the reaction is first order (n ≈ 1) with respect to drug concentration. 
Evaluation of the kinetic methods: 
Several experiments were carried out to obtain the drug concentration from the rate data according to 
the corresponding equation (1). Rate constant, fixed absorbance and fixed time methods were tried and 
the most suitable analytical method was selected taking in consideration applicability, sensitivity and 
correlation coefficient. 
Rate constant method: 
Graph of log (absorbance) versus time in seconds over the concentration range 7.12x10-8 – 4.27x10-7 
M was plotted and the pseudo-first order constant (k`) corresponding to different drug concentrations 
were calculated from slopes multiplied by -2.303 and presented in (Table 5, Fig.16). 
K` = -1x 10-3 – 9.341x102 C 
r2 = 0.887 
Fixed absorbance method: 
Reaction rates were recorded for different concentrations of ranitidine HCl (7.12x10-8 – 4.27x10-7 M). 
A preselected value of absorbance 0.36 was fixed and time was measured in seconds. The reciprocal of 
time (1/t) versus the different drug concentrations was plotted (Table 6, fig. 17). 
1/t = 3.6 x 10-4 + 4.28 x 103 C 
r2 = 0.9963 
Fixed time method: 
Reaction rates were determined for different concentrations of ranitidine HCl. 
Calibration graph of absorbance versus initial concentration of ranitidine HCl was established at fixed 
time of 5, 10, 15, 20, and 25 and 30 minutes with the calibration equations (Table 7). It was clear that the 
slope and the correlation coefficient increase with time. The best correlation coefficient for ranitidine HCl 
was obtained for a fixed time of 25 minutes; therefore this fixed time was used for its measurement. 
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Table 1 Analytical parameters and spectral data for spectrophotometric determination of omeprazole 
sodium and ranitidine HCl through method I and II  
 
Parameter 
Method I 
(DNFB) 
Method II 
(NBD-Cl) 
Omeprazole 
sodium 
Ranitidine 
HCl 
Omeprazole 
sodium 
Ranitidine HCl 
λmax, nm 470 nm 420 nm 481 nm 468 nm 
Borate buffer ;pH 10.5 10.5 10.8 9.8 
Borate buffer volume (ml) 1.5 ml 2 ml 1 ml 0.8 ml 
Reagent Conc. 0.3%v/v  0.3%v/v  0.4%w/v 
 
0.4%w/v 
 
Reagent volume (ml) 0.4 ml 1.5 ml 1 ml 1 ml 
Temperature (oC) 70oC 80oC 80oC 60oC 
Reaction time (min.) 15 min. 20 min. 15 min. 25 min. 
Diluting solvent Methanol Methanol Methanol Methanol 
Beer’s law limits (µg.ml-1) 5-40 µg/ml 30-180 
µg/ml 
2-12µg/ml 0.025-0.15µg/ml 
Regression 
equation* 
Slope (b) 0.02 0.004 0.0714 6.771 
Intercept (a) 0.074 0.077 0.191 0.076 
Variance 0.488 0.236 0.993 0.936 
Correlation coefficient 0.999 0.999 0.999 0.999 
Molar absorptivity**      
(L.Mol-1.cm-1 ) 
9.202 x 103 1.778 x 103 4.062 x 104 2.802 x 106 
Sandell’s sensitivity 
(µg.cm-2) 
2.02 x 10-2 1.04 x 10-1 5.2 x 10-3 7.12 x 10-5 
Limit of detection; LOD(µg.ml-1) 1.48 7.44 0.297 0.002 
Limit of quantification; 
LOQ(µg.ml-1) 
4.51 22.55 0.900 0.006 
*A = a + bC where A is absorbance, C is the concentration of the drug in µg.ml-1; **Calculated in the 
basis of molecular weight of the drug. 
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Table 2 Statistical data for determination of omeprazole sodium and ranitidine HCl using method I and 
method II compared with the reference method. 
Statistic Omeprazole sodium Ranitidine HCl 
Reference 
method(45) 
Method I Method II Reference 
method(46) 
Method I Method II 
Mean 
recovery*± 
SD 
100±0.700 99.65±0.418 100.62±0.987 100.8±0.722 101.11±0.519 100.28±0.869 
RSD 0.69 0.419 0.981 0.716 0.513 0.867 
N 5 5 5 5 5 5 
Variance 0.53 0.175 0.97 0.521 0.270 0.756 
S.E. 0.313 0.187 0.442 0.323 0.233 0.309 
t-test**  0.961 1.827  0.780 1.030 
F-test**  2.80 1.988  1.935 1.448 
 * Average of three experiments; **Theoretical t and F values are 2.306and 5.05, respectively at p=0.05. 
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Table 3 Statistical data for determination of pharmaceutical preparation of omeprazole sodium and 
ranitidine HCl through method I and method II compared with the reference method. 
 
 
Statistic
s 
Omeprazole sodium Ranitidine HCl 
Pepzol® capsules                   Aciloc® 
tablets 
Zantac® ampoules 
Refere
nce 
metho
d 
Method I Method 
II 
Referenc
e 
method 
Method I Method 
II 
Method 
I 
Method 
II 
Mean 
recover
y*± 
SD 
100±0.
70 
100.79±0
.912 
100.85±
0.65 
100.8±0.
722 
100.44±0
.596 
101.18±0
.642 
100.86±
0.61 
100.64±
0.55 
N 5 5 5 5 5 5 5 5 
Varianc
e 
0.53 0.342 0.310 0.521 0.041 0.518 0.47 0.29 
S.E. 0.313 0.409 0.320 0.323 0.298 0.321 0.3 0.27 
t-test**  1.539 1.99 
 
 0.860 0.879 0.142 0.395 
F-test**  1.145 1.16 
 
 1.467 1.264 1.4 1.723 
* Average of three experiments; **Theoretical t and F values are 2.306and 5.05, respectively at p=0.05. 
 
Table 4 Logarithms of rates for different concentrations of ranitidine HCl 
Log ΔA/Δt Log [conc.] (M) 
 
-3.883 -7.14 
-3.603 -6.84 
-3.407 -6.67 
-3.301 -6.54 
-3.191 -6.44 
-3.123 -6.37 
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Table 5 Values of k  `calculated from slopes of log A versus time for ranitidine HCl 
K  `(S-1) [conc.] (M) 
-0.98 x 10-3 7.12 x 10-8 
-1.1 x 10-3 1.42 x 10-7 
-1.25 x 10-3 2.13 x 10-7 
-1.25 x 10-3 2.85 x 10-7 
-1.37 x 10-3 3.56 x 10-7 
-1.38 x 10-3 4.27 x 10-7 
 
Table 6 Values of reciprocal of time taken at fixed absorbance for different rates of variable concentrations of 
ranitidine HCl 
1/t (s-1) [conc.] (M) 
9.95 x 10-4 1.43 x 10-7 
1.25 x 10-3 2.14 x 10-7 
1.58 x 10-3 2.85 x 10-7 
1.85 x 10-3 3.56 x 10-7 
2.22 x 10-3 4.28 x 10-7 
1/t = 3.6 x 10-4 + 4.28 x 103 C 
r2 = 0.9963 
 
Table 7 Regression equations at different fixed time for ranitidine HCl in  concentration range 7.12 x 10-8 – 
4.27 x 10-7 M. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time (min.) Regression equations Correlation coefficient (r2) 
5 0.0634  + 0.7897 C 0.9832 
10 0.0374  + 3.144 C 0.9888 
15 0.1036  + 3.850 C 0.9926 
20 0.1128  + 5.032 C 0.9882 
25 0.0686  + 6.828 C 0.9996 
30 0.005  + 6.811 C 0.9833 
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Fig. 1 Absorption spectra of (method I) for the reaction between DNFB and 10 µg.ml-1omeprazole sodium at 
λmax 470 nm and 80 µg.ml-1 ranitidine HCl at λmax 420 nm. 
 
 
 
 
 
 
 
 
 
 
 
Fig.2 Absorption spectra of (method II) for the reaction between NBD-Cl and 6µg.ml-1omeprazole sodium at 
λmax 481 nm and 0.05 µg.ml-1 ranitidine HCl at λmax 468 nm. 
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Fig. 3 Effect of buffer pH on the reaction of DNFB with 10 µg.ml-1 omeprazole sodium and 60 µg.ml-1 
ranitidine HCl. 
 
 
 
 
 
 
 
Fig. 4 Effect of buffer pH on the reaction of NBD-Cl with 4 µg.ml-1 omeprazole sodium and 1µg.ml-1 ranitidine 
HCl. 
 
 
 
 
 
 
 
 
 
 
Fig. 5 Effect of buffer volume on the reaction of DNFB with 10 µg.ml-1 omeprazole sodium and 60 µg.ml-1 
ranitidine HCl. 
  
  
Ivy Union Publishing | http: //www.ivyunion.org September 5, 2014 | Volume 1 | Issue 1
  
Page 17 of 21 Baraka MM et al. American Journal of Current Analytical Chemistry 2014, 1:1-23 
 
 
 
 
 
 
 
Fig. 6 Effect of buffer volume on the reaction of NBD-Cl with 4 µg.ml-1 omeprazole sodium and 1 µg.ml-1 
ranitidine HCl. 
 
 
 
 
 
 
 
 
 
Fig.7 Effect of DNFB volume (ml) on the reaction of DNFB with 10 µg.ml-1 omeprazole sodium and 60 
µg.ml-1 ranitidine HCl. 
 
 
 
 
 
 
Fig. 8 Effect of NBD-Cl volume (ml) on the reaction of NBD-Cl with 4 µg.ml-1 omeprazole sodium and 1 
µg.ml-1 ranitidine HCl. 
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Fig. 9 Effect of temperature (oC) on the reaction of DNFB with 10 µg.ml-1 omeprazole sodium and 60 µg.ml-1 
ranitidine HCl. 
 
 
 
 
 
 
Fig. 10 Effect of temperature (oC) on the reaction of NBD-Cl with4 µg.ml-1 omeprazole sodium and 1 µg.ml-1 
ranitidine HCl. 
 
 
 
 
 
 
Fig. 11 Effect of heating time (min.) on the reaction of DNFB with10 µg.ml-1omeprazole sodium and 60 
µg.ml-1 ranitidine HCl. 
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Fig. 12 Effect of heating time (min.) on the reaction of NBD-Cl with 4 µg.ml-1 omeprazole sodium and 1 
µg.ml-1 ranitidine HCl. 
 
 
 
 
 
 
 
 
Fig. 13 Effect of volume of 0.1M HCl on the reaction of DNFB with 10 µg.ml-1 omeprazole sodium and 60 
µg.ml-1 ranitidine HCl. 
 
 
 
 
 
 
Fig. 14 Effect of volume of 0.1M HCl on the reaction of NBD-Cl with 4 µg.ml-1 omeprazole sodium and 1 
µg.ml-1 ranitidine HCl. 
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Fig. 15 Absorbance versus time graphs for the reaction between ranitidine HCl and NBD-Cl at different 
concentrations of ranitidine HCl. 
1= 7.12x10-8 M           2=1.42x10-7M           3=2.13x10-7M 
4=2.85x10-7M             5=3.56x10-7M            6=4.27x10-7M 
 
 
 
 
 
 
 
 
 
Fig. 16 Values of k`(s-1) calculated from slopes of different log absorbance versus t graph multiplied by -2.303 
for different concentrations of ranitidine HCl. 
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Fig. 17 Values of reciprocal of time taken at fixed absorbance for different rates of variable concentrations of 
ranitidine HCl. 
 
Conclusion 
The proposed spectrophotometric methods provided simple, sensitive, specific and inexpensive analytical 
procedures for determination of the cited drugs either in pure forms or in their pharmaceutical formulations 
without interference from common excipients. The satisfactory sensitivity and reproducibility as well as the 
convenience and simplicity, make the two proposed methods suitable for routine analysis in quality control 
laboratories. 
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